Among the various components of the plasminogen system, urokinase-type plasminogen activator (uPA), together with its receptor, play a pivotal role in cancer progression and metastasis, while uPA is regulated through the MAPK or PI3K-AKT signaling pathways in CC [26]. Here, PLAU is linked to cancer.